Integral Diagnostics Ltd · ASX:IDX
Integral Diagnostics — Shareholder Meeting (October 2025)
8 slides from Integral Diagnostics's shareholder meeting presentation, Oct 31, 2025
Slide 1: 2025 Annual General Meeting – Chair's Address and Presentation
Integral Diagnostics Limited 2025 Annual General Meeting – Chair’s Address and Presentation I am very pleased to be addressing you today. Integral Diagnostics is a healthcare company built on excellent foundations and values. Our services dramatically improve the diagnosis and treatment of illness a
Slide 2: Chair's address: Sustainability
Our increased scale, improving margins and successful integration of Capitol means that IDX is well placed to take advantage of additional M&A growth opportunities as they arise and industry consolidation continues. Sustainability This year we made significant progress embedding sustainability into
Slide 3: Chair's address: Board and CEO succession
Our new Directors have brought specific skills and experience the Board, including specialist medical perspectives to the Board’s decision making. I’m very pleased with the way the Board has come together to deliver effective oversight and strategic guidance. Our new Directors are standing for elect
Slide 4: Chair Address – Toby Hall, Chair
For personal use only CHAIR ADDRESS Toby Hall - Chair
Slide 5: Improving Performance Over Time, Enhanced by Merger with Capitol Health
IMPROVING PERFORMANCE OVER TIME, ENHANCED BY MERGER WITH CAPITOL HEALTH Operating Revenue Operating EBITDA 700.0 628.0 140.0 126.5 For personal use only 600.0 120.0 500.0 469.7 100.0 91.5 440.8 85.2 AUD $ms 74.8 AUD $ms 400.0 360.9 80.0 300.0 60.0 200.0 40.0 100.0 20.0 - - FY22 FY23 FY24 FY25 FY22 F
Slide 6: Merger with Capitol Health – IDX Operational Platform Strengthened
MERGER WITH CAPITOL HEALTH - IDX OPERATIONAL PLATFORM STRENGTHENED • High quality network of 145 clinics across Australia Enhanced 145 Total IDX sites and New Zealand with ~460 employed and contracted operational radiologists and ~3,000 staff. For personal use only scale and IDXt coverage • GP and s
Slide 7: Sustainability
SUSTAINABILITY FY25 Actions FY26 Planned Actions Quantified emissions reduction targets in our FY25 Renewable electricity For personal use only Sustainability Report Finalise centralised procurement model. Set emissions reduction targets: 42% reduction in Scope 1 & Supplier engagement 2 by 2030 from
Slide 8: Governance
GOVERNANCE • Two new Non-Executive Directors, Ms Laura McBain and Dr Kevin Shaw, joined the Board from Capitol Health. For personal use only • Dr Manish Mittal was appointed as a Radiologist Director1 to ensure a specialist medical perspective is an intrinsic part of our decision making. • IDX expec
Integral Diagnostics — Shareholder Meeting (October 2025) on 6ix